In contrast to our results, the previous meta-analysis reported that being a BRCA mutation carrier (BRCA1 and/or BRCA2) is associated with a significant increase in PCa risk, with BRCA2 mutation being associated with a greater risk of PCa than BRCA1 [15]. This evidence concerns the gene BRCA1 and posterior cortical atrophy.